Follow Us On Facebook
500 W san Bernardino RD, STE A, Covina, CA 91722
Call :
626-966-1909 | Email : info@drmetyas.com
Patient PortalPay NowVirtual Visit

PUBLICATIONS

1- Diet and Lifestyle Modifications for Fibromyalgia
https://pubmed.ncbi.nlm.nih.gov/35220935/

2- Subcategories of Fibromyalgia: A New Concept
https://pubmed.ncbi.nlm.nih.gov/35220935/

3- Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series
https://pubmed.ncbi.nlm.nih.gov/35152867/

4- Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
https://pubmed.ncbi.nlm.nih.gov/35081280/

5- Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis
https://pubmed.ncbi.nlm.nih.gov/36001712/

5- Low Dose Naltrexone in the Treatment of Fibromyalgia
https://pubmed.ncbi.nlm.nih.gov/28325149/

6- Trial of Anifrolumab in Active Systemic Lupus Erythematosus 
https://pubmed.ncbi.nlm.nih.gov/31851795/

7- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
https://pubmed.ncbi.nlm.nih.gov/29527974/

8- Combination Therapy of Apremilast and Biologic Agent as a Safe Option of Psoriatic Arthritis and Psoriasis
https://pubmed.ncbi.nlm.nih.gov/30499418/

9- Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomized controlled trial 
https://pubmed.ncbi.nlm.nih.gov/28629665/

10- Cryoneurolysis to treat the pain and symptoms of knee osteoarthritis: a multicenter, randomized, double-blind, sham-controlled trial
https://pubmed.ncbi.nlm.nih.gov/28336454/

11- Autoinflammation and Immunomodulation in Inflammatory Fibromyalgia Syndrome- A Review
https://pubmed.ncbi.nlm.nih.gov/27655626/

12- Improvement of Nerve Fiber Density in Fibromyalgia Patients Treated with IVIg. 
https://pubmed.ncbi.nlm.nih.gov/31702528/

13- Inflammatory Fibromyalgia: Is it Real?
https://pubmed.ncbi.nlm.nih.gov/26002453/

14- Hip arthroplasty in a 101-year-old patient.
https://pubmed.ncbi.nlm.nih.gov/16357745/

15- Rituximab treatment for resistant antiphospholipid syndrome.
https://pubmed.ncbi.nlm.nih.gov/16465669/

16- Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab
https://pubmed.ncbi.nlm.nih.gov/24576278/

17- Giant cell arteritis with visual loss following zoledronic acid infusion.
https://pubmed.ncbi.nlm.nih.gov/24472274/

18- Pregnancy in a patient with gouty arthritis secondary to pseudo-Bartter syndrome
https://pubmed.ncbi.nlm.nih.gov/20661067/

19- Inflammatory arthritis secondary to metastatic gastric cancer.
https://pubmed.ncbi.nlm.nih.gov/14719219/

20- Infliximab treatment of Familial Mediterranean fever and its effect on secondary AA amyloidosis 
https://pubmed.ncbi.nlm.nih.gov/17043487/

21- Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis
https://pubmed.ncbi.nlm.nih.gov/18762943/

22- Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud’s disease
https://pubmed.ncbi.nlm.nih.gov/16981288/

23- The use of the tumor necrosis factor antagonist infliximab in heart transplant recipients: two case reports 
https://pubmed.ncbi.nlm.nih.gov/17934084/

24- B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations
https://pubmed.ncbi.nlm.nih.gov/14673998/

25-  Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus
https://pubmed.ncbi.nlm.nih.gov/15308519/